Setoperone Explained

Setoperone is a compound that is a ligand to the 5-HT2A receptor.It can be radiolabeled with the radioisotope fluorine-18 and used as a radioligand with positron emission tomography (PET).Several research studies have used the radiolabeled setoperone in neuroimaging for the studying neuropsychiatric disorders, such as depression[1] or schizophrenia.[2]

Synthesis

The starting material is called 6-(2-hydroxyethyl)-7-methyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-5-one, CID:15586462 (1). Halogenation of this with hydrobromic acid in acetic acid gives CID:15586463 (2). Sn2 alkylation with 4-(4-fluorobenzoyl)piperidine [56346-57-7] (3) under Finkelstein reaction conditions affords setoperone (4).

See also

Notes and References

  1. Jeffrey H. Meyer, Shitij Kapur, Sylvain Houle, Jean DaSilva, Beata Owczarek, Gregory M. Brown, Alan A. Wilson and Sidney H. Kennedy. Prefrontal Cortex 5-HT2 Receptors in Depression: An [18F]Setoperone PET Imaging Study. American Journal of Psychiatry. 156. 1029–1034. 10401447. 7. July 1, 1999 . 10.1176/ajp.156.7.1029. 453720.
  2. Ralph Lewis, Shitij Kapur, Corey Jones, Jean DaSilva, Gregory M. Brown, Alan A. Wilson, Sylvain Houle and Robert B. Zipursky. Serotonin 5-HT2 Receptors in Schizophrenia: A PET Study Using [18F]Setoperone in Neuroleptic-Naive Patients and Normal Subjects. American Journal of Psychiatry. 156. 72–78. 9892300. 1. January 1, 1999 . 10.1176/ajp.156.1.72.